Vermont Business Magazine The State of Vermont, and Burlington Laboratories, Inc. and Burlington Labs, LLC (together “Burlington Labs”), have reached an agreement settling an investigation by the Medicaid Fraud and Residential Abuse Unit of the Office of the Attorney General into whether Burlington submitted false claims or received overpayments from the Vermont Medicaid Program. Burlington Labs will pay $6.75 million to settle potential claims under the Vermont False Claims Act. “This settlement balances the ongoing needs for drug testing services in Vermont with ensuring proper billings for services rendered and safeguarding of state and federal monies,” said Attorney General William H. Sorrell. Burlington Labs is an independent toxicology laboratory, headquartered in Burlington, Vermont. The settlement resolves an investigation into Burlington Labs’ Medicaid claims related to drug screening and certain confirmatory tests. The investigation revealed that from January 1, 2015, through June 30, 2015, Burlington Labs violated a number of Medicaid rules regarding such tests including …
Go to Source
Burlington Labs to pay $6.75 million to settle Medicaid false claims case